Poxel Aktie - POXEL

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

0,228

Gebot

0,225

Fragen

0,224

Volumen

0,00

0,00 Tagesbereich 0,00

0,115 52-Wochen-Bereich 0,898

Marktkapitalisierung

10,622M

Handelsende

0,228

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

789.724

Ausgegebene Aktien

46.586.753

Dividendenrendite

Kurs-Gewinn-Verhältnis

-0,31

Gewinn pro Aktie (EPS)

-0,75

Erlöse

1,98M

Nettogewinn

-35,09M

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.poxelpharma.com

Hauptsitz

Lyon, Rhone, Fra

Gegründet

Poxel is listed in the Pharmaceutical Preparations sector of the Euronext with ticker POXEL. The last closing price for Poxel was 0,23 €. Over the last year, Poxel shares have traded in a share price range of 0,115 € to 0,898 €.

Poxel currently has 46.586.753 shares in issue. The market capitalisation of Poxel is 10,62 € million. Poxel has a price to earnings ratio (PE ratio) of -0.31.

Poxel Announces Results of its Combined General Meeting Held on February 11, 2025

Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for...

Poxel publie les ventes brutes de TWYMEEG® au Japon pour le quatrième trimestre 2024 et les prévisions de vente pour l'exercice 2024 annoncées par son partenaire Sumitomo Pharma

Les ventes de TWYMEEG® continuent de progresser au Japon, en hausse de 17% sur le dernier trimestre 2024 (octobre-décembre) par rapport au...

Poxel annonce son agenda financier pour l’exercice 2025

Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), société biopharmaceutique au stade clinique développant des traitements innovants...

Poxel: Ordinary and Extraordinary General Meeting to Be Held on February 11, 2025

Poxel announces that a Combined General Meeting will be held on February 11, 2025, at 9:00 a.m. CET and the availability of the preparatory...

Poxel annonce la délivrance d’un brevet en Chine protégeant l’utilisation de l’Imeglimine chez les patients diabétiques de type 2 atteints d’insuffisance rénale

Durée de vie des brevets couvrant l’Imeglimine en Chine étendue jusqu’en 2039 Poursuite des discussions en vue d’un partenariat pour le...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.057	-20	0.285	0.285	0.2025	588570	0.24959503	DE
4	-0.004	-1.72413793103	0.232	0.3985	0.2025	1207610	0.3047413	DE
12	-0.0005	-0.218818380744	0.2285	0.3985	0.115	789724	0.24914514	DE
26	-0.36	-61.2244897959	0.588	0.687	0.115	490156	0.30342139	DE
52	-0.281	-55.2062868369	0.509	0.898	0.115	394034	0.41675884	DE
156	-3.672	-94.1538461538	3.9	3.9	0.115	202274	0.63840161	DE
260	-10.112	-97.7949709865	10.34	10.44	0.115	171973	2.32731808	DE

POXEL - Frequently Asked Questions (FAQ)

What is the current Poxel share price?

The current share price of Poxel is 0,228 €

How many Poxel shares are in issue?

Poxel has 46.586.753 shares in issue

What is the market cap of Poxel?

The market capitalisation of Poxel is EUR 10,62M

What is the 1 year trading range for Poxel share price?

Poxel has traded in the range of 0,115 € to 0,898 € during the past year

What is the PE ratio of Poxel?

The price to earnings ratio of Poxel is -0,31

What is the cash to sales ratio of Poxel?

The cash to sales ratio of Poxel is 5,41

What is the reporting currency for Poxel?

Poxel reports financial results in EUR

What is the latest annual turnover for Poxel?

The latest annual turnover of Poxel is EUR 1,98M

What is the latest annual profit for Poxel?

The latest annual profit of Poxel is EUR -35,09M

What is the registered address of Poxel?

The registered address for Poxel is 259/261 AVENUE JEAN JAURES - IMMEUBLE LE SUNWAY, LYON, RHONE, 69007

What is the Poxel website address?

The website address for Poxel is www.poxelpharma.com

Which industry sector does Poxel operate in?

Poxel operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
ABCAABC Arbitrage	5,31 € (0,00%)	0
ABAb Science	1,54 € (0,00%)	0
AALBAalberts NV	35,70 € (0,00%)	0
AAAAlan Allman Associates	4,64 € (0,00%)	0
74SW74Software SA	27,70 € (0,00%)	0
ABCAABC Arbitrage	5,31 € (0,00%)	0
ABAb Science	1,54 € (0,00%)	0
AALBAalberts NV	35,70 € (0,00%)	0
AAAAlan Allman Associates	4,64 € (0,00%)	0
74SW74Software SA	27,70 € (0,00%)	0
ABCAABC Arbitrage	5,31 € (0,00%)	0
ABAb Science	1,54 € (0,00%)	0
AALBAalberts NV	35,70 € (0,00%)	0
AAAAlan Allman Associates	4,64 € (0,00%)	0
74SW74Software SA	27,70 € (0,00%)	0

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Poxel (POXEL)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Poxel

POXEL Neueste Nachrichten

Poxel Announces Results of its Combined General Meeting Held on February 11, 2025

Poxel publie les ventes brutes de TWYMEEG® au Japon pour le quatrième trimestre 2024 et les prévisions de vente pour l'exercice 2024 annoncées par son partenaire Sumitomo Pharma

Poxel annonce son agenda financier pour l’exercice 2025

Poxel: Ordinary and Extraordinary General Meeting to Be Held on February 11, 2025

Poxel annonce la délivrance d’un brevet en Chine protégeant l’utilisation de l’Imeglimine chez les patients diabétiques de type 2 atteints d’insuffisance rénale

Poxel Announces Results of its Combined General Meeting Held on February 11, 2025

Poxel’s partner Sumitomo Pharma reports TWYMEEG® gross sales in Japan for Q4 2024 and FY 2024 sales forecast

Poxel annonce son agenda financier pour l’exercice 2025

Poxel : Assemblée générale ordinaire et extraordinaire du 11 février 2025

Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type-2 Diabetic Patients with Renal Impairment

Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan

POXEL : Bilan semestriel du contrat de liquidité contracté avec ODDO BHF SCA

Poxel : nombre d’actions et de droits de vote composant le capital social

POXEL - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Poxel (POXEL) Börsenkurse

Poxel (POXEL)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Poxel

POXEL Neueste Nachrichten

Poxel Announces Results of its Combined General Meeting Held on February 11, 2025

Poxel publie les ventes brutes de TWYMEEG® au Japon pour le quatrième trimestre 2024 et les prévisions de vente pour l'exercice 2024 annoncées par son partenaire Sumitomo Pharma

Poxel annonce son agenda financier pour l’exercice 2025

Poxel: Ordinary and Extraordinary General Meeting to Be Held on February 11, 2025

Poxel annonce la délivrance d’un brevet en Chine protégeant l’utilisation de l’Imeglimine chez les patients diabétiques de type 2 atteints d’insuffisance rénale

Poxel Announces Results of its Combined General Meeting Held on February 11, 2025

Poxel’s partner Sumitomo Pharma reports TWYMEEG® gross sales in Japan for Q4 2024 and FY 2024 sales forecast

Poxel annonce son agenda financier pour l’exercice 2025

Poxel : Assemblée générale ordinaire et extraordinaire du 11 février 2025

Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type-2 Diabetic Patients with Renal Impairment

Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan

POXEL : Bilan semestriel du contrat de liquidité contracté avec ODDO BHF SCA

Poxel : nombre d’actions et de droits de vote composant le capital social

POXEL - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen